Vanguard Personalized Indexing Management LLC Has $556,000 Stock Position in Chemed Co. (NYSE:CHE)

Vanguard Personalized Indexing Management LLC reduced its stake in shares of Chemed Co. (NYSE:CHE) by 8.2% in the 2nd quarter, Holdings Channel.com reports. The firm owned 1,102 shares of the company’s stock after selling 98 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in Chemed were worth $556,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently bought and sold shares of CHE. Mercer Global Advisors Inc. ADV increased its holdings in shares of Chemed by 4.7% during the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 1,545 shares of the company’s stock worth $838,000 after purchasing an additional 70 shares during the period. Bradley Foster & Sargent Inc. CT acquired a new position in shares of Chemed in the 2nd quarter valued at $250,000. Edgestream Partners L.P. lifted its holdings in shares of Chemed by 748.8% during the 2nd quarter. Edgestream Partners L.P. now owns 13,640 shares of the company’s stock worth $7,401,000 after acquiring an additional 12,033 shares during the period. Quantbot Technologies LP boosted its position in shares of Chemed by 135.3% during the 2nd quarter. Quantbot Technologies LP now owns 7,057 shares of the company’s stock valued at $3,829,000 after acquiring an additional 4,058 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in Chemed by 19.1% in the second quarter. Dimensional Fund Advisors LP now owns 153,957 shares of the company’s stock valued at $83,536,000 after acquiring an additional 24,721 shares during the period. 95.85% of the stock is owned by institutional investors.

Insider Buying and Selling at Chemed

In other Chemed news, EVP Nicholas Michael Westfall sold 1,713 shares of the company’s stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $569.35, for a total transaction of $975,296.55. Following the sale, the executive vice president now directly owns 6,109 shares of the company’s stock, valued at $3,478,159.15. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other news, Director George J. Walsh III sold 200 shares of the firm’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $577.95, for a total value of $115,590.00. Following the completion of the sale, the director now directly owns 3,446 shares in the company, valued at $1,991,615.70. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Nicholas Michael Westfall sold 1,713 shares of the company’s stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $569.35, for a total transaction of $975,296.55. Following the transaction, the executive vice president now owns 6,109 shares in the company, valued at approximately $3,478,159.15. The disclosure for this sale can be found here. Insiders have sold a total of 6,744 shares of company stock worth $3,828,231 over the last ninety days. Corporate insiders own 3.32% of the company’s stock.

Chemed Stock Up 0.8 %

Shares of CHE opened at $600.50 on Friday. The company has a 50-day moving average price of $573.42 and a two-hundred day moving average price of $576.78. The stock has a market cap of $9.09 billion, a price-to-earnings ratio of 32.32, a P/E/G ratio of 2.40 and a beta of 0.44. Chemed Co. has a 12 month low of $497.36 and a 12 month high of $654.62.

Chemed (NYSE:CHE) last posted its earnings results on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing the consensus estimate of $5.59 by ($0.12). Chemed had a return on equity of 29.21% and a net margin of 12.88%. The company had revenue of $595.88 million for the quarter, compared to the consensus estimate of $599.20 million. During the same quarter last year, the business earned $4.71 EPS. Chemed’s quarterly revenue was up 7.6% compared to the same quarter last year. Equities research analysts expect that Chemed Co. will post 21.77 EPS for the current fiscal year.

Chemed Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Monday, August 12th were given a dividend of $0.50 per share. The ex-dividend date was Monday, August 12th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.33%. This is a boost from Chemed’s previous quarterly dividend of $0.40. Chemed’s dividend payout ratio (DPR) is 10.76%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.